+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

North American DNA Vaccine Market 2019-2025

  • PDF Icon


  • February 2020
  • Region: North America
  • Orion Market Research Private Limited
  • ID: 5116595
North American DNA Vaccine Market Size, Share & Trends Analysis Report by Type (Animal DNA Vaccine, Human DNA Vaccine) By Technology (Plasmid DNA Vaccine and Plasmid DNA Delivery) By Application (Oncology, Infectious Disease, and Others) Forecast period (2019-2025).

The North American DNA Vaccine market is anticipated to grow at a CAGR 42.8% during the forecast period. North America is creating a significant opportunity for the DNA vaccination market. Several types of research have been conducted by medical research centers in the region. For instance, In Dec 2017, the National Institute of Allergy and Infectious Diseases (NIAID), a part of NIH (National Institute of Health) has developed a Gene-based Zika vaccine. The center developed two different plasmids for clinical testing, including VRC5283 and VRC5288. In clinical trials, it was found that vaccinations are safe; however, some participants experienced swelling, redness and inflammation at the injection site.

Moreover, increasing funding for activities for DNA vaccinations is also primarily driving the DNA vaccination market in North America. As an instance, In Jan 2018, Bill and Melinda Gates Foundation have granted $1.4 million to the Wistar Institute (Philadelphia) to develop a synthetic DNA-based vaccine for malaria.

Further, the North American market is analyzed on the basis of the countries that are contributing significantly towards the growth of the market. The North American market is further bifurcated into the United States and Canada. North American DNA vaccine is further segmented into type, technology and application. Based on type, the market is segmented into animal DNA vaccine and human DNA vaccine. Based on technology, the market is segmented into plasmid DNA vaccine and plasmid DNA delivery. Based on application, the market is segmented into oncology, infectious disease and others.

The key market player that are active in the market includes Arbutus Biopharma Corp., Dendreon Pharmaceuticals LLC, GE Healthcare, GlaxoSmithKline PLC., Green Cross Corp., Innovio Biomedical Corp., Immunomic Therapeutics, Merck & Co., Pfizer Inc., Protein Sciences Corp., Qed Biosciences Inc., Sanofi Inc., Tolerion Inc., Vical Inc. and Zoetis Inc. The market players are considerably contributing to the market growth by the adoption of various strategies including new product launch, merger, and acquisition, collaborations with government, funding to the start-ups and technological advancements to stay competitive in the market.

Research Methodology:

The market study of the North American DNA Vaccine market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The research team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to the reports.

Secondary Sources Include:
  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation:

1. North American DNA Vaccine Market Research and Analysis by Type
2. North American DNA Vaccine Market Research and Analysis by Technology
3. North American DNA Vaccine Market Research and Analysis by Application

The Report Covers:
  • Comprehensive Research Methodology of the North American DNA Vaccine market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the North American DNA Vaccine market.
  • Insights about market determinants which are stimulating the North American DNA Vaccine market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Arbutus Biopharma Corp.
  • Dendreon Pharmaceuticals LLC
  • GE Healthcare
  • Glaxosmithkline PLC.
  • Green Cross Corp.
  • Immunomic Therapeutics
  • Innovio Biomedical Corp.
  • Merck & Co.
  • Pfizer Inc.
  • Protein Sciences Corp.
  • Qed Biosciences Inc.
  • Sanofi Inc.
  • Tolerion Inc.
  • Vical Inc.
  • Zoetis Inc.